Specimen adequacy · Satisfactory for evaluation o Presence or absence of endocervical or
transformation zone components or o Other quality indicators such as partially obscuring
blood or inflammation · Unsatisfactory for evaluation (specify reason) General categorization(optional) · Negative for intraepithelial lesion or malignancy · Epithelial cell abnormality · Other Interpretation/result · Negative for intraepithelial lesion or malignancy o Organisms § Trichomonas vaginalis § Fungal organisms morphologically consistent with
Candida spp. § Shift in flora suggestive of bacterial vaginosis § Bacteria morphologically consistentwithActinomyces
spp. § Cellular changes consistent with Herpes
simplexvirus. o Other non-neoplastic findings § Reactive cellular changes § Glandular cells status post hysterectomy § Atrophy · Epithelial cell abnormalities o Squamous cell § Atypical squamous cells (ASC) Atypical squamous cells of undetermined
significance (ASC-US) ASC, cannot exclude High grade squamous
intraepithelial lesion(ASC-H) § Low grade squamous intraepithelial lesion (LSIL)
encompassing: human papilloma virus (HPV)/mild dysplasia/CIN 1 § High grade squamous intraepithelial lesion (HSIL)
encompassing: moderate and severe dysplasia, CIS/CIN 2 and CIN3 with features suspicious for invasion (if invasion
is suspected) § Squamous cell carcinoma o Glandular cell § Atypical glandular cells (AGC) § Atypical glandular cells, favour neoplastic § Endocervical adenocarcinoma in situ (AIS) § Adenocarcinoma · Other malignant neoplasms |
Sr No |
Cytological findings |
Frequency no (% ) |
1 |
NILM |
|
Normal smears |
124(24.41%) |
|
Inflammatory Lesions |
324(63.78%) |
|
2 |
Epithelial lesions |
60(11.81%) |
|
Total |
508(100%) |
|
Age group (Years) |
||||||
Cytological findings |
15-30 |
31-40 |
41-50 |
51-60 |
61-70 |
≥71 |
Total (%) |
Cervicitis |
95 |
138 |
63 |
12 |
2 |
0 |
310(60.22%) |
Trichomonas Vaginalis |
2 |
2 |
1 |
0 |
0 |
0 |
5(0.98%) |
Atrophy |
0 |
0 |
1 |
1 |
3 |
2 |
7(1.4%) |
Bacterial vaginosis |
0 |
1 |
0 |
0 |
0 |
0 |
1(0.2%) |
Herpes simplex |
1 |
0 |
0 |
0 |
0 |
0 |
1(0.2%) |
Normal smears |
37 |
55 |
22 |
7 |
2 |
1 |
124(24.409%) |
ASCUS |
3 |
8 |
15 |
1 |
2 |
0 |
29(5.7%) |
AGUS |
0 |
1 |
3 |
0 |
0 |
0 |
4(0.78%) |
ASCUS/LSIL |
3 |
1 |
1 |
1 |
0 |
0 |
6(1.18%) |
LSIL |
2 |
3 |
1 |
1 |
0 |
0 |
7(1.4%) |
HSIL |
0 |
2 |
1 |
2 |
2 |
0 |
7(1.4%) |
SCC |
0 |
2 |
2 |
1 |
0 |
0 |
5(1%) |
Adenocarcinoma |
0 |
0 |
0 |
0 |
0 |
0 |
0(0%) |
HSIL/SCC |
0 |
1 |
0 |
0 |
0 |
0 |
1(0.2%) |
Endometrial Ca |
0 |
1 |
0 |
0 |
0 |
0 |
1(0.2%) |
Total |
143 |
215 |
110 |
26 |
11 |
3 |
508(100%) |
Range: 22- 77 years |